News

Paul Bruhn Joins Hofseth BioCare ASA as New Business Head

Paul Bruhn Joins Hofseth BioCare ASA as New Business Head

Hofseth BioCare ASA Welcomes Paul Bruhn as Head of Development

Hofseth BioCare ASA (Oslo:HBC) is thrilled to share the exciting news of Paul Bruhn's appointment as the new Head of New Business Development. With over 25 years of experience in healthcare and medical nutrition, Bruhn brings a wealth of knowledge that aligns perfectly with the company’s vision.

Extensive Experience in Healthcare and Nutrition

Mr. Bruhn’s impressive background includes leadership roles at industry giants like Novartis Medical Nutrition and Nestle Health Science, where he operated across various key regions such as Asia, the Middle East, and Australia. His global perspective and expertise in clinical nutrition and consumer healthcare make him a valuable addition to Hofseth BioCare.

A Vision for Innovation

In his new role, Bruhn emphasizes the growing demand for clinically-backed nutrition solutions. He highlights Hofseth BioCare's specialty ingredients as essential for meeting market needs. "I am eager to contribute to taking HBC to new heights, especially as we amplify our business in Asia and across the ANZ region," Bruhn stated.

Unique Bioactive Ingredients from HBC

Hofseth BioCare has established itself as a pioneer in developing a unique portfolio of bioactive ingredients. Their products, including OmeGo®, ProGo®, NT-II™, and PetGo®, are derived from sustainably sourced salmon. Unlike conventional fish oils, OmeGo® is a full-spectrum salmon oil that ensures all beneficial Omega fatty acids are preserved, promoting heart health and providing anti-inflammatory benefits.

Commitment to Sustainability and Health

As a leading Norwegian company, Hofseth BioCare prioritizes sustainability and optimal resource utilization. The company specializes in transforming waste from the salmon industry into valuable health ingredients. By upcycling side streams, HBC not only contributes to environmental sustainability but also enhances the well-being of humans and pets.

Scientific Backing and Health Benefits

Hofseth BioCare's ingredients are supported by scientific research and partnerships with academia. For instance, ProGo® has shown promise in improving iron metabolism, increasing energy, and supporting vitality. Similarly, OmeGo® has been linked to enhanced immune function and improved sleep in individuals affected by pollution.

Patents and Future Innovations

HBC’s innovative work has led to multiple patents that protect their groundbreaking discoveries, paving the way for potential therapeutics. The company has recently established HBC Immunology, focused on biotech developments for serious health conditions, including prostate and ovarian cancer.

What Lies Ahead for Hofseth BioCare?

With Bruhn at the helm of new business development, there are high expectations for Hofseth BioCare's future initiatives and product innovations. The company's commitment to creating high-quality and scientifically backed health solutions aligns with the growing consumer demand for transparent and effective nutrition sources.

Contact Information

For more insights, please reach out to:

James Berger, CCO at Hofseth BioCare ASA
Phone: +41 79 950 1034
E-mail: jb@hofsethbiocare.no

About Hofseth BioCare ASA

Founded on the principles of sustainability and traceability, Hofseth BioCare ASA leads the way in valuing all parts of the salmon. Their innovative approach not only fosters environmental stewardship but also prioritizes consumer health with unique, bioactive ingredients designed for the next generation.

Frequently Asked Questions

Who is Paul Bruhn?

Paul Bruhn is the newly appointed Head of New Business Development at Hofseth BioCare ASA, bringing over 25 years of experience in healthcare.

What are the main products offered by Hofseth BioCare?

Hofseth BioCare offers a range of bioactive ingredients including OmeGo®, ProGo®, NT-II™, and PetGo®, all derived from sustainably sourced salmon.

How does Hofseth BioCare prioritize sustainability?

The company emphasizes upcycling salmon industry by-products to create health ingredients, ensuring full utilization of natural resources and sustainability.

What are the health benefits of OmeGo®?

OmeGo® provides a full spectrum of Omega fatty acids, promoting heart health, reducing inflammation, and offering significant immune health benefits.

Where is Hofseth BioCare located?

Hofseth BioCare's headquarters are in Ålesund, Norway, with additional branches in Oslo, London, Zürich, Los Angeles, and Palo Alto.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 146

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 69

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 142

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 155

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 85

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Conagra Brands: Navigating Challenges with Strong Dividends and Growth

Updated Category News Views 164

Conagra's Market Position and Opportunities Conagra Brands Inc (NYSE: CAG) shares are currently experiencing a significant dip, providing a favorable opportunity for long-term investors to consider entry into the market. Despite the ongoing challenges that are affecting the consumer staples sector, Conagra has ended its recent business contraction. The company's...

Continue Reading
Unlocking the Potential of AeroVironment Stock Investments

Updated Category News Views 215

The Growth Journey of AeroVironment (NASDAQ: AVAV) AeroVironment continues to impress investors with its steady performance over recent years. This aerospace company specializes in drone technology and has showcased remarkable growth potential in a competitive industry. Despite the challenges posed by changing market conditions, AeroVironment has outperformed the market...

Continue Reading
Focal One® Robotic HIFU Shows Promise in Prostate Cancer Care

Updated Category News Views 131

Groundbreaking Results from the HIFI Study The HIFI Study stands as a significant milestone in the treatment of localized prostate cancer, presenting remarkable findings and setting the stage for a shift in medical practices. This extensive research, with a participant group of 3,328, compares HIFU treatment using Focal One® against traditional surgery methods,...

Continue Reading
VENU's Ambitious Growth Strategy Secures $34.5 Million Funding

Updated Category News Views 307

VENU Secures Funding to Propel Its Growth Strategy In recent news, VENU (NYSE American: VENU), a company leading the charge in premium hospitality and live entertainment, has successfully closed a public offering. This offering involved 2,875,000 shares of common stock, sold at a public price of $12.00 each, bringing in $34.5 million in gross proceeds. This substantial...

Continue Reading
Exploring Market Trends in the Food Colors Industry

Updated Category News Views 250

The food colors market saw a hefty rise, hitting projections of USD 6.0 billion by 2028 from USD 4.6 billion in 2023. This growth came at a compound annual growth rate (CAGR) of about 5.4%, thanks to shifting consumer preferences towards naturally sourced and visually appealing products. Market Dynamics: The Push for Natural Colors Back then, the processed food scene was...

Continue Reading